Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

Oncolytic Herpes Simplex Virus and PI3K Inhibitor BKM120 Synergize to Promote Killing of Prostate Cancer Stem-like Cells

Novel therapies to override chemo-radiation resistance in prostate cancer (PCa) are needed. Prostate cancer sphere-forming cells (PCSCs) (also termed prostate cancer stem-like cells) likely participate in tumor progression and recurrence, and they are important therapeutic targets. We established PC...

Full description

Bibliographic Details
Main Authors:	Lei Wang, Jianfang Ning, Hiroaki Wakimoto, Shulin Wu, Chin-lee Wu, Melissa R. Humphrey, Samuel D. Rabkin, Robert L. Martuza
Format:	Article
Language:	English
Published:	Elsevier 2019-06-01
Series:	Molecular Therapy: Oncolytics
Online Access:	http://www.sciencedirect.com/science/article/pii/S2372770519300403

Similar Items

Oncolytic Herpes Simplex Virus-based Strategies: Toward a Breakthrough in Glioblastoma Therapy
by: Jianfang eNing, et al.
Published: (2014-06-01)

Oncolytic Herpes Simplex Virus-Based Therapies for Cancer
by: Norah Aldrak, et al.
Published: (2021-06-01)

Combination of Oncolytic Herpes Simplex Viruses Armed with Angiostatin and IL-12 Enhances Antitumor Efficacy in Human Glioblastoma Models
by: Wei Zhang, et al.
Published: (2013-06-01)

Oncolytic herpes simplex virus and immunotherapy
by: Wenqing Ma, et al.
Published: (2018-12-01)

Oncolytic herpes simplex virus kills stem-like tumor-initiating colon cancer cells
by: Susanne G Warner, et al.
Published: (2016-01-01)

Activity of BKM120 and BEZ235 against Lymphoma Cells
by: Monica Civallero, et al.
Published: (2015-01-01)

BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma.
by: Ping Zhao, et al.
Published: (2017-01-01)

Designing herpes viruses as oncolytics
by: Cole Peters, et al.
Published: (2015-01-01)

Enhancement of oncolytic herpes simplex type 1 virotherapy
by: Delwar, Zahid M.
Published: (2017)

PI3k inhibitors (BKM120 and BYL719) as radiosensitizers for head and neck squamous cell carcinoma during radiotherapy.
by: Fu-Cheng Chuang, et al.
Published: (2021-01-01)

The Current State of Oncolytic Herpes Simplex Virus for Glioblastoma Treatment
by: Nguyen HM, et al.
Published: (2021-02-01)

Presage of oncolytic virotherapy for oral cancer with herpes simplex virus
by: Yoshiaki Yura
Published: (2017-05-01)

Oncolytic Herpes Simplex Virus Therapy for the Treatment of Pediatric Rhabdomyosarcoma
by: Leddon, Jennifer
Published: (2015)

BKM120 sensitizes glioblastoma to the PARP inhibitor rucaparib by suppressing homologous recombination repair
by: Shaolu Zhang, et al.
Published: (2021-05-01)

Evaluation of In Vitro Activity of the Class I PI3K Inhibitor Buparlisib (BKM120) in Pediatric Bone and Soft Tissue Sarcomas.
by: Jennifer L Anderson, et al.
Published: (2015-01-01)

Herpes Simplex Virus Oncolytic Immunovirotherapy: The Blossoming Branch of Multimodal Therapy
by: Laura Menotti, et al.
Published: (2020-11-01)

Modulation of the Intratumoral Immune Landscape by Oncolytic Herpes Simplex Virus Virotherapy
by: Jie Yin, et al.
Published: (2017-06-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of neuroblastoma.
by: Lauren A Gillory, et al.
Published: (2013-01-01)

Oncolytic herpes simplex virus infects myeloma cells in vitro and in vivo
by: Jayeeta Ghose, et al.
Published: (2021-03-01)

Potent anti-tumor effects of receptor-retargeted syncytial oncolytic herpes simplex virus
by: Takuma Suzuki, et al.
Published: (2021-09-01)

Temozolomide antagonizes oncolytic immunovirotherapy in glioblastoma
by: Dipongkor Saha, et al.
Published: (2020-06-01)

Replication-Competent Herpes Simplex Virus Vector G207 and Cisplatin Combination Therapy for Head and Neck Squamous Cell Carcinoma
by: Ali Chahlavi, et al.
Published: (1999-06-01)

MicroRNA-145 Regulates Oncolytic Herpes Simplex Virus-1 for Selective Killing of Human Non-Small Cell Lung Cancer Cells
by: Jhy-Ming Li, et al.

Oncolytic Herpes Simplex Virus Prevents Premalignant Lesions from Progressing to Cancer
by: Yanghee Woo, et al.
Published: (2020-03-01)

Generation of an Oncolytic Herpes Simplex Virus 1 Expressing Human MelanA
by: Jan B. Boscheinen, et al.
Published: (2019-01-01)

Construction and characterisation of second generation oncolytic herpes simplex viruses for cancer therapy
by: Dunn, Paul Damien
Published: (2003)

Oncolytic Herpes Simplex Virus Inhibits Pediatric Brain Tumor Migration and Invasion
by: Julia V. Cockle, et al.
Published: (2017-06-01)

The Role of Natural Killer Cells in the Context of Oncolytic Herpes Simplex Virotherapy for Glioblastoma
by: Alvarez-Breckenridge, Christopher
Published: (2011)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
by: Joshua D. Bernstock, et al.
Published: (2021-06-01)

Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
by: Xiao-Qin Liu, et al.
Published: (2018-01-01)

Phase 2 study of buparlisib (BKM120), a pan-class I PI3K inhibitor, in patients with metastatic triple-negative breast cancer
by: Ana C. Garrido-Castro, et al.
Published: (2020-11-01)

Effect of Repeat Dosing of Engineered Oncolytic Herpes Simplex Virus on Preclinical Models of Rhabdomyosarcoma
by: Alicia M. Waters, et al.
Published: (2016-10-01)

A novel fusogenic herpes simplex virus for oncolytic virotherapy of squamous cell carcinoma
by: Iwai Soichi, et al.
Published: (2011-06-01)

Oncolytic virotherapy using herpes simplex virus: how far have we come?
by: Sokolowski NAS, et al.
Published: (2015-11-01)

Entry of Oncolytic Herpes Simplex Virus into Human Squamous Cell Carcinoma Cells by Ultrasound
by: Shusuke Okunaga, et al.
Published: (2015-10-01)

Preclinical evaluation of engineered oncolytic herpes simplex virus for the treatment of pediatric solid tumors.
by: Michael L Megison, et al.
Published: (2014-01-01)

Characterization and oncolytic virus targeting of FAP-expressing tumor-associated pericytes in glioblastoma
by: Ming Li, et al.
Published: (2020-12-01)

Flip-Flop HSV-BAC: bacterial artificial chromosome based system for rapid generation of recombinant herpes simplex virus vectors using two independent site-specific recombinases
by: Todo Tomoki, et al.
Published: (2006-09-01)

The Effect of Herpes Simplex Virus-Type-1 (HSV-1) Oncolytic Immunotherapy on the Tumor Microenvironment
by: Ifeanyi Kingsley Uche, et al.
Published: (2021-06-01)

Engineering and Characterization of Oncolytic Vaccinia Virus Expressing Truncated Herpes Simplex Virus Thymidine Kinase
by: S. M. Bakhtiar Ul Islam, et al.
Published: (2020-01-01)